Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for prevention of vancomycin-induced nephrotoxicity in ICU patients
IRCT20240501061620N1Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in acute kidney failure (AKF) and drug-induced nephropathy (DIN), sponsored by Semnan University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
curcumin
03
Conditions
acute kidney failure (AKF)drug-induced nephropathy (DIN)
Beyond the preview
Go deeper on IRCT20240501061620N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240501061620N1.